{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:40:26Z","timestamp":1740123626001,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10875-021-01100-9","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T05:02:53Z","timestamp":1626411773000},"page":"1701-1705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BCG Vaccine\u2013Associated Complications in Patients with PTEN Hamartoma Tumor Syndrome"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9066-9151","authenticated-orcid":false,"given":"Henry","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Aschenbrenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holm H.","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","volume":"8","author":"S Fekrvand","year":"2020","unstructured":"Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract United States. 2020;8:1371\u201386.","journal-title":"J Allergy Clin Immunol Pract United States"},{"key":"1100_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med Annual Reviews. 2020;71:103\u201316.","journal-title":"Annu Rev Med. Annual Reviews"},{"issue":"12","key":"1100_CR3","doi-asserted-by":"publisher","first-page":"a036996","DOI":"10.1101\/cshperspect.a036996","volume":"9","author":"H Taylor","year":"2019","unstructured":"Taylor H, Laurence ADJ, Uhlig HH. The role of PTEN in innate and adaptive immunity. Cold Spring Harb Perspect Med. 2019;9(12):a036996.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1100_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2016.03.059","volume":"139","author":"HH Chen","year":"2017","unstructured":"Chen HH, H\u00e4ndel N, Ngeow J, Muller J, H\u00fchn M, Yang HT, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol Elsevier. 2017;139:607-620.e15.","journal-title":"J Allergy Clin Immunol. Elsevier"},{"key":"1100_CR5","first-page":"1093","volume":"142","author":"M Heindl","year":"2012","unstructured":"Heindl M, Handel N, Ngeow J, Kionke J, Wittekind C, Kamprad M, et al. Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome. Gastroenterology United States. 2012;142:1093-1096.e6.","journal-title":"Gastroenterology. United States"},{"key":"1100_CR6","doi-asserted-by":"crossref","unstructured":"Taylor H, Yerlioglu D, Phen C, Ballauff A, Nedelkopolou N, Spier I, et al. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in juvenile polyposis of infancy due to PTEN-BMPR1A deletion syndrome. Hum Mol Genet.\u00a02021;30(14):1273.","DOI":"10.1093\/hmg\/ddab094"},{"key":"1100_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cyto.b.21728","volume":"96","author":"M Garcia-Prat","year":"2019","unstructured":"Garcia-Prat M, \u00c1lvarez-Sierra D, Aguil\u00f3-Cucurull A, Salgado-Perandr\u00e9s S, Briongos-Sebastian S, Franco-Jarava C, et al. Extended immunophenotyping reference values in a healthy pediatric population. Cytom Part B Clin Cytom John Wiley & Sons, Ltd. 2019;96:223\u201333.","journal-title":"Cytom Part B Clin Cytom John Wiley & Sons, Ltd"},{"key":"1100_CR8","doi-asserted-by":"publisher","first-page":"e22420","DOI":"10.1002\/jcla.22420","volume":"32","author":"M Garcia-Prat","year":"2018","unstructured":"Garcia-Prat M, Vila-Pijoan G, Martos Gutierrez S, Gala Yerga G, Garc\u00eda Guantes E, Mart\u00ednez-Gallo M, et al. Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the OptiliteTM automated turbidimetric analyzer. J Clin Lab Anal Wiley Online Library. 2018;32:e22420.","journal-title":"J Clin Lab Anal. Wiley Online Library"},{"key":"1100_CR9","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jaci.2016.03.055","volume":"138","author":"Y Tsujita","year":"2016","unstructured":"Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, et al. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase \u03b4 syndrome\u2013like immunodeficiency. J Allergy Clin Immunols Elsevier Inc. 2016;138:1672\u201380.","journal-title":"J Allergy Clin Immunols. Elsevier Inc"},{"key":"1100_CR10","doi-asserted-by":"crossref","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24\u201364.","DOI":"10.1007\/s10875-019-00737-x"},{"key":"1100_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase & #x3b4; syndrome: A\u00a0large patient cohort study. J Allergy Clin Immunol Elsevier. 2017;139:597-606.e4.","journal-title":"J Allergy Clin Immunol. Elsevier"},{"key":"1100_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase & #x3b4; syndrome 2: A\u00a0cohort study. J Allergy Clin Immunol Elsevier. 2016;138:210-218.e9.","journal-title":"J Allergy Clin Immunol. Elsevier"},{"key":"1100_CR13","doi-asserted-by":"crossref","unstructured":"Nunes-Santos CJ, Rosenzweig SD. Bacille Calmette-Guerin complications in newly described primary immunodeficiency Diseases: 2010\u20132017. Front Immunol Frontiers. 2018;9:1423.","DOI":"10.3389\/fimmu.2018.01423"},{"key":"1100_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2015.12.008","volume":"178","author":"M Chiriaco","year":"2017","unstructured":"Chiriaco M, Brigida I, Ariganello P, Di Cesare S, Di Matteo G, Taus F, et al. The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment. Clin Immunol. 2017;178:20\u20138.","journal-title":"Clin Immunol"},{"issue":"19","key":"1100_CR15","first-page":"3743","volume":"38","author":"YJE Sloot","year":"2019","unstructured":"Sloot YJE, Rabold K, Netea MG, Smit JWA, Hoogerbrugge N, Netea-Maier RT. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome. Oncogene Nature Publishing Group. 2019;38(19):3743\u201355.","journal-title":"Oncogene. Nature Publishing Group"},{"key":"1100_CR16","doi-asserted-by":"publisher","first-page":"23196","DOI":"10.1074\/jbc.M112.351940","volume":"287","author":"GC Huang","year":"2012","unstructured":"Huang GC, Redelman-Sidi G, Rosen N, Glickman MS, Jiang XJ. Inhibition of mycobacterial infection by the tumor suppressor PTEN. J Biol Chem. 2012;287:23196\u2013202.","journal-title":"J Biol Chem"},{"key":"1100_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong X-F, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update. Immunol Cell Biol. 2019;97:360\u20137.","journal-title":"Immunol Cell Biol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01100-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T05:12:31Z","timestamp":1632114751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01100-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients consented to clinical research via the Oxford GI biobank. They have consented to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}},{"value":"HC and HHU received research support by UCB Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}